Recall: D-0010-2027

Class II - Potentially Harmful

Class IIClassification
2026-09-17Initiated
OngoingStatus
Ajanta Pharma USA IncFirm

Product

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

Reason

Failed Dissolution Specifications: below specification

Distribution

Nationwide in the US.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.